Concepedia

Nadja Rohdich

NR

5

Publications

209

Citations

5

H-Index

2009

Active since

Affiliations

MSD (Switzerland)(Current)

Nadja Rohdich is an author at MSD (Switzerland) specializing in antibiotics, infection control, and sepsis.

Top concepts

Publications per year

2009–2021

5

Publications

5

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs

Nadja Rohdich, Rainer K. A. Roepke, Eva Zschiesche · Parasites & Vectors · 2014 · 144 citations · Full text

Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats

Nadja Rohdich, Eva Zschiesche, Oliver Wolf et al. · Parasites & Vectors · 2018 · 20 citations · Full text

Efficacy, safety and palatability of a new broad‐spectrum anthelmintic formulation in dogs

Kathrin Schmid, Nadja Rohdich, E. Zschiesche et al. · Veterinary Record · 2010 · 18 citations

Treatment of septicaemia and severe bacterial infections in foals with a new cefquinome formulation: a field study.

Nadja Rohdich, E. Zschiesche, Anja R. Heckeroth et al. · PubMed · 2009 · 14 citations

, , +18

Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats

Katharina Raue, Nadja Rohdich, Daniela Hauck et al. · Parasites & Vectors · 2021 · 13 citations · Full text

Rows per page

1–5 of 5